Cardinal Health (CAH) FY2025 10-K Annual Report
Cardinal Health (CAH) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Aug 12, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Cardinal Health FY2025 10-K Analysis
Risk Factors
- • Legal risk: Potential exposure from product liability and self-insurance accruals noted in loss contingencies, specifics not quantified but integral to financial estimates
- • Geopolitical exposure: GMPD segment manufacturing facilities in 12 countries including Germany, Japan, Malaysia, Mexico, and Costa Rica, subject to international operational risks
- • Operational vulnerability: Inventories increased to $16.8B in 2025 from $15.0B in 2024, indicating susceptibility to supply chain disruptions affecting working capital
- • Competitive risk: Goodwill impairment testing required for Navista & ION and Cardinal Health at-Home Solutions reporting units shows sensitivity to revenue growth and market conditions
- • Financial risk: Long-term obligations rose to $8.0B in 2025 from $4.7B in 2024, increasing leverage and interest expense to $215M, up from $51M prior year
Cardinal Health FY2025 Key Financial MetricsXBRL
Revenue
$222.6B
▼ -1.9% YoY
Net Income
$1.6B
▲ +83.2% YoY
Gross Margin
3.7%
▲ +40bp YoY
Operating Margin
1.0%
▲ +47bp YoY
Net Margin
0.7%
▲ +33bp YoY
ROE
-56.1%
▼ -2961bp YoY
Total Assets
$53.1B
▲ +17.7% YoY
EPS (Diluted)
$6.45
▲ +87.0% YoY
Operating Cash Flow
$2.4B
▼ -36.3% YoY
Source: XBRL data from Cardinal Health FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Cardinal Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.